Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis
出版年份 2023 全文链接
标题
Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-01-20
DOI
10.3389/fphar.2023.1110146
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ferroptosis inducers for prostate cancer therapy
- (2022) Nadia Zaffaroni et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the androgen receptor signaling pathway in advanced prostate cancer
- (2022) Clement Chung et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth
- (2022) Sheng Zhan et al. BRITISH JOURNAL OF CANCER
- Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming
- (2022) Meng-Ting Chang et al. PHARMACOLOGICAL RESEARCH
- Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation
- (2022) Wenchang Yang et al. Frontiers in Pharmacology
- Molecular mechanisms of reactive oxygen species in regulated cell deaths: Impact of ferroptosis in cancer therapy
- (2022) Morteza Golbashirzadeh et al. Gene Reports
- Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis
- (2022) Zhibin Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Second generation androgen receptor antagonists and challenges in prostate cancer treatment
- (2022) Yanhua Chen et al. Cell Death & Disease
- Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma
- (2022) Xiaofeng Kang et al. Frontiers in Oncology
- Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
- (2022) Mamello Sekhoacha et al. MOLECULES
- Overexpression of LncRNA MNX1-AS1/PPFIA4 Activates AKT/HIF-1α Signal Pathway to Promote Stemness of Colorectal Adenocarcinoma Cells
- (2022) Qi Sun et al. Journal of Oncology
- Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
- (2022) Govinda Nanjaiah Laxmana Raju et al. Journal of Laboratory Physicians
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis
- (2021) Ke Ren et al. Frontiers in Oncology
- A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer
- (2021) Daniel Westaby et al. Annual Review of Pharmacology and Toxicology
- LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC
- (2021) Yantao Liu et al. Cancer Cell International
- Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
- (2021) Aasems Jacob et al. Cancers
- Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation
- (2020) Lian‐Dong Shen et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
- (2020) Xiang Song et al. Frontiers in Oncology
- LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2
- (2019) Na Huang et al. Frontiers in Oncology
- Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1
- (2018) Xiaowei Diao et al. ONCOLOGY REPORTS
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer
- (2016) Marcella Bassetto et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
- (2014) Antoine Angelergues et al. EUROPEAN JOURNAL OF CANCER
- Steroid Receptor Coactivator-3 Regulates Glucose Metabolism in Bladder Cancer Cells through Coactivation of Hypoxia Inducible Factor 1α
- (2014) Wei Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site
- (2013) Kurtis Eisermann et al. Molecular Cancer
- Overcoming Drug Resistance and Treating Advanced Prostate Cancer
- (2012) Julius Semenas et al. CURRENT DRUG TARGETS
- Suppression of the androgen receptor function by quercetin through protein–protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells
- (2010) Huiqing Yuan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started